Gerard Griffioen,Bart De Taeye,Katrien Princen,Koen De Witte,Emilie Blanche,Hasane Ratni,Mark Rogers-Evans
申请号：
US15433164
公开号：
US20170157137A1
申请日:
2017.02.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to a compound of formula (I) or a stereoisomer, enantiomer, racemic, or tautomer thereof, Formula (I), wherein R1, R3, R4, L1, L2, L3, L4, and n, have the same meaning as that defined in the claims and the description. The present invention also relates to compositions, in particular pharmaceuticals, comprising such compounds, and to uses of such compounds and compositions for the prevention and/or treatment of metabolic disorders and/or neurodegenerative diseases, and/or protein misfolding disorders.
